Cargando…
Romosozumab: a novel bone anabolic treatment option for osteoporosis?
Research into the drug romosozumab began with the investigation of patients with excess bone formation. The understanding of the wingless-type mouse mammary tumor virus integration site (Wnt) signaling pathway in bone metabolism identified the negative regulator of bone mass sclerostin as a potentia...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Vienna
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098919/ https://www.ncbi.nlm.nih.gov/pubmed/31858345 http://dx.doi.org/10.1007/s10354-019-00721-5 |